Skip to main content
HLB INC. logo

HLB INC. — Investor Relations & Filings

Ticker · 028300 ISIN · KR7028300002 LEI · 988400ZL885PLZG8E576 KO Manufacturing
Open in API
Filings indexed 555 across all filing types
Latest filing 2020-05-26 Capital/Financing Update
Country KR South Korea
Listing KO 028300

About HLB INC.

https://www.hlb.global/

HLB INC. is a biopharmaceutical company focused on developing new global anti-cancer drugs. The company's core activities center on advancing a pipeline of novel therapeutics through its worldwide network, which includes subsidiaries like Elevar Therapeutics and Immunomic Therapeutics. In addition to its primary focus on oncology, HLB's affiliated companies are involved in other life science areas, such as developing and manufacturing in vitro diagnostic medical devices, peptide-based biomaterials, and quasi-drugs. The group also has operations in composite materials and shipbuilding, reflecting its diversified origins.

Recent filings

Filing Released Lang Actions
전환가액의조정(제33회차)
Capital/Financing Update Classification · 95% confidence The document is a formal regulatory filing regarding the adjustment of the conversion price for convertible bonds (CB) due to a capital increase (rights offering). This type of disclosure, which details changes to the terms of financial instruments like convertible bonds, falls under capital structure updates. In the provided taxonomy, 'CAP' (Capital/Financing Update) is the most appropriate category for adjustments to conversion prices of debt instruments.
2020-05-26 Korean
[기재정정]투자설명서
Investor Presentation Classification · 95% confidence The document is a '정정신고(보고)' (Amendment Report) for an '투자설명서' (Investment Prospectus/Securities Registration Statement). It details specific amendments made to the original filing, including updates to financial information (Q1 2020), risk factors, and business developments (e.g., Immunomic Therapeutics stake acquisition, Oasmia Pharmaceutical agreement). In the context of financial filings, a document that amends a previously filed securities registration statement or prospectus is classified as a 'POS' (Registration Statement/Prospectus) or a regulatory filing related to capital changes. Given the specific nature of the document as a formal amendment to a prospectus, it falls under the category of a registration statement/prospectus filing.
2020-05-25 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details changes in share ownership by major shareholders and their special related parties. This type of filing is categorized as a 'Major Shareholding Notification' (MRQ) in the provided schema.
2020-05-15 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Korean Financial Supervisory Service. This type of filing is a mandatory disclosure by company insiders (directors/major shareholders) regarding their personal share transactions and current holdings. In the provided taxonomy, this corresponds to 'Director's Dealing' (DIRS), which covers reports of personal share transactions by company directors and executives.
2020-05-12 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act (Article 147). It details changes in share ownership by major shareholders (Jin Yang-gon and special related parties) of HLB Co., Ltd. This type of filing is specifically categorized as a 'Major Shareholding Notification' (MRQ) in the provided schema, as it tracks significant ownership thresholds and changes.
2020-05-12 Korean
[기재정정]증권신고서(지분증권)
Capital/Financing Update Classification · 95% confidence The document is a 'Correction Report' (정정신고) for a 'Securities Registration Statement' (증권신고서) regarding equity securities. It details amendments to previously filed information, specifically concerning the major shareholder's share disposal and participation in a capital increase (rights offering). In the context of Korean financial filings (DART system), this is a regulatory filing related to capital changes and financing, which falls under the 'Capital/Financing Update' category.
2020-05-12 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.